Background: A review of randomized controlled trials of weight-management interventions for pregnant or postpartum women was conducted to assess whether effective weight-management interventions exist for this population.
Methods: The MEDLINE, EMBASE, PsycINFO, Sociological Abstracts, and CINAHL databases were searched, as well as the reference lists of relevant publications. English-language articles published between January 1985 and August 2007 that used a randomized controlled trial study design and incorporated a weight-related outcome measure were reviewed. All potentially relevant articles were reviewed separately, and final selections were based on consensus reached through discussion.
Results: Three studies met the inclusion criteria, one conducted among pregnant women and two among postpartum women. The interventions addressed modifications in diet and exercise and included individual or group-counseling sessions combined with written and telephone correspondence or food and exercise diaries. In two studies, the weight-related outcome was significantly better in the intervention group than in the control group. The third study found a significant interaction between weight category and intervention group. In all studies, the refusal or attrition rates were high.
Conclusions: While these studies indicate that interventions can help pregnant and postpartum women manage their weight, many questions remain unanswered. Several research gaps for weight-management interventions in this important population have been identified.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/j.amepre.2008.02.010 | DOI Listing |
SAGE Open Med
January 2025
Endocrinology Diabetes, Metabolism, and Obesity Medicine, Obesity, Endocrine, and Metabolism Center (OEMC), King Fahad Medical City (KFMC), Riyadh, Saudi Arabia.
Objectives: To explore the impact of obesity on clinical outcomes, health-related quality of life, emotional well-being, and work productivity in people/patients with obesity across six countries by body mass index and the presence of complications.
Methods: Adelphi Real World Obesity Disease Specific Programme™ captured data related to physicians and their consulting people/patients with obesity on a weight management program or anti-obesity medication in Brazil, Canada, China, Japan, Kingdom of Saudi Arabia, and the United Arab Emirates from April to December 2022. Physicians reported data for up to eight qualifying people/patients with obesity.
BMC Pregnancy Childbirth
January 2025
Obstetrician and Gynecologist, Department of Obstetrics and Gynecology, Cheng-Hsin General Hospital, Taipei, Taiwan.
Background: Obesity and excessive gestational weight gain (GWG) have been linked to an increased risk of cesarean section. However, existing literature primarily focuses on weight gain during individual trimesters, lacking a comprehensive assessment of GWG trajectories across all three trimesters. This study aimed to investigate the impact of pre-pregnancy BMI and changes in GWG trajectories from the first to the third trimester on cesarean section in women with confirmed gestational diabetes mellitus (GDM).
View Article and Find Full Text PDFDigit Health
January 2025
Ohad Cohen Endocrinology, Tel Hashomer, Israel.
Objective: The objective of this pilot study is to evaluate the feasibility of using an automatic weight management system to follow patients' response to weight reduction medications and to identify early deviations from weight trajectories.
Methods: The pilot study involved 11 participants using Semaglutide for weight management, monitored over a 12-month period. A cloud-based, Wi-Fi-enabled remote weight management system collected and analyzed daily weight data from smart scales.
Int J Obes (Lond)
January 2025
Center for Optometry, Gansu Provincial Hospital, Lanzhou, China.
Background: Multiple meta-analyses (MAs) have demonstrated that six pharmacotherapies, including orlistat, liraglutide, phentermine/topiramate, naltrexone/bupropion, semaglutide, and tirzepatide, improve weight loss and weight maintenance. However, few studies have synthesized and evaluated the quality of this evidence.
Objective: To identify the relevant MAs of randomized clinical trials (RCTs) that explored the association between the six pharmacotherapies and obesity-related health outcomes and adverse events (AEs).
Nutrients
January 2025
Department of Endocrinology and Diabetes, Nagoya University Graduate School of Medicine, Nagoya 466-8550, Japan.
Objective: In treating obesity, energy intake control is essential to avoid exceeding energy expenditure. However, excessive restriction of energy intake often leads to resting energy expenditure (REE) reduction, increasing hunger and making weight loss difficult. This study aimed to investigate whether providing nutritional guidance that considers energy expenditure based on the regular evaluation of REE and physical activity could effectively reduce body weight (BW) in patients with obesity.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!